title: Molecular imaging in pulmonary diseases.
abstract: OBJECTIVE
  In this article, we consider a multitude of the latest techniques used for evaluating benign and malignant pulmonary diseases. Our review will include mostly clinically pertinent studies, but we have also included breakthrough basic science research that has potentially significant clinical implications.
  
  
  CONCLUSIONS
  Molecular imaging enables noninvasive visualization and measurement of the dynamic molecular processes within living organisms. Early recognition of molecular and cellular malfunctions can help optimize diagnostic and therapeutic strategies.
authors.affiliation: Department of Radiology, Division of Nuclear Medicine, University of California, Davis, Medical Center, 2315 Stockton Blvd, Room 1893, Sacramento, CA 95817, USA. amir.kashefi@ucdmc.ucdavis.edu
authors.forename: Amir
authors.initials: A
authors.lastname: Kashefi
authors.forename: Jonathan
authors.initials: J
authors.lastname: Kuo
authors.forename: David K
authors.initials: DK
authors.lastname: Shelton
mesh_terms: D000900:Anti-Bacterial Agents; D017209:Apoptosis; D003937:Diagnosis, Differential; D042241:Early Diagnosis; D006801:Humans; D000860:Hypoxia; D007962:Leukocytes; D008171:Lung Diseases / Q000175:diagnosis* / Q000503:physiopathology; D057054:Molecular Imaging / Q000379:methods*; D019275:Radiopharmaceuticals; D012129:Respiratory Function Tests
chemical_list: D000900:Anti-Bacterial Agents; D019275:Radiopharmaceuticals